Lazard Balance Sheet Health
Financial Health criteria checks 3/6
Lazard has a total shareholder equity of $732.4M and total debt of $1.9B, which brings its debt-to-equity ratio to 254%. Its total assets and total liabilities are $4.2B and $3.5B respectively.
Key information
253.97%
Debt to equity ratio
US$1.86b
Debt
| Interest coverage ratio | n/a |
| Cash | US$909.95m |
| Equity | US$732.36m |
| Total liabilities | US$3.50b |
| Total assets | US$4.23b |
Recent financial health updates
No updates
Recent updates
Lazard: Lots Of Positives But Asset Management Is A Drag
Jun 23Lazard, Inc. (NYSE:LAZ) Stock Rockets 29% But Many Are Still Ignoring The Company
May 09
Lazard, Inc. (NYSE:LAZ) Could Be Riskier Than It Looks
Mar 14Lazard, Inc.'s (NYSE:LAZ) Shares Bounce 26% But Its Business Still Trails The Industry
Nov 07Lazard: Aggressive Hiring Means Peer-Leading Growth
Nov 01
Decisive Expansions And Innovative Asset Management Propel Future Revenue Growth
Expansion into Private Capital Advisory and strategic hires in sponsor coverage are set to enhance Lazard's advisory revenue and market share.Lazard: Still Decent Value
Aug 08Even With A 33% Surge, Cautious Investors Are Not Rewarding Lazard, Inc.'s (NYSE:LAZ) Performance Completely
Jul 26Lazard: Liability Management Pickup, Markets Equilibrating
May 17Lazard: 5% Dividend Yield And Expected Growth Driven By Rebound In M&A And Equity Markets
Feb 18Financial Position Analysis
Short Term Liabilities: LAZ's short term assets ($1.9B) exceed its short term liabilities ($252.1M).
Long Term Liabilities: LAZ's short term assets ($1.9B) do not cover its long term liabilities ($3.2B).
Debt to Equity History and Analysis
Debt Level: LAZ's net debt to equity ratio (129.7%) is considered high.
Reducing Debt: LAZ's debt to equity ratio has reduced from 349.4% to 254% over the past 5 years.
Debt Coverage: LAZ's debt is well covered by operating cash flow (33.1%).
Interest Coverage: Insufficient data to determine if LAZ's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/15 19:09 |
| End of Day Share Price | 2025/07/15 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lazard, Inc. is covered by 26 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephen Biggar | Argus Research Company |
| Michael Needham | BofA Global Research |
| James Mitchell | Buckingham Research Group Inc. |